Alterity Financial Group’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-9,346
Closed -$366K – 74
2023
Q3
$366K Sell
9,346
-3,138
-25% -$125K 0.58% 47
2023
Q2
$507K Buy
12,484
+198
+2% +$8.15K 0.73% 38
2023
Q1
$514K Sell
12,286
-288
-2% -$12.1K 0.75% 40
2022
Q4
$548K Sell
12,574
-302
-2% -$12.8K 0.89% 36
2022
Q3
$500K Sell
12,876
-208
-2% -$8.86K 0.81% 37
2022
Q2
$555K Buy
+13,084
New +$568K 0.83% 37
2021
Q4
$710K Buy
+14,649
New +$693K 0.76% 41
2021
Q1
$624K Buy
+13,718
New +$650K 0.75% 39

Other funds holding BME

Alterity Financial Group's BME Position: Q4 2023 in Review

Alterity Financial Group sold out of BlackRock Health Sciences Trust (BME) in Q4 2023, closing a stake of 9,346 shares — an estimated $366K sold.

Alterity Financial Group first reported a position in BME in Q1 2021 and held it in 8 quarters. The position peaked at $710K in Q4 2021. 73 funds tracked by Wall St. Rank hold BME as of Q4 2023.

  • Alterity Financial Group reported no remaining BlackRock Health Sciences Trust position as of Q4 2023 after selling out during the quarter.
  • Alterity Financial Group sold 9,346 BlackRock Health Sciences Trust shares in Q4 2023, an estimated $366K.
  • Alterity Financial Group first reported a position in BlackRock Health Sciences Trust in Q1 2021 and held it in 8 quarters.
  • Alterity Financial Group's BlackRock Health Sciences Trust position peaked at $710K in Q4 2021.
  • 73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2023.

Based on Alterity Financial Group's 13F filing for Q4 2023, filed 18 Jan 2024.